A33 (Cefuroxime 250 mg)
Pill imprint A33 has been identified as Cefuroxime axetil 250 mg.
Cefuroxime is used in the treatment of bacterial infection; urinary tract infection; bladder infection; sinusitis; skin and structure infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- A33
- Strength:
- 250 mg
- Color:
- White
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Aurobindo Pharma Limited
- National Drug Code (NDC):
- 65862-0034
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hydrogenated cottonseed oil
microcrystalline cellulose
sodium lauryl sulfate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 65862-0699 | Aurobindo Pharma Limited |
| 16714-0400 | NorthStar Rx LLC |
| 21695-0370 | Rebel Distributors Corp (repackager) |
| 53002-0275 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More about cefuroxime
Consumer resources
- Cefuroxime
- Cefuroxime suspension
- Cefuroxime tablets
- Cefuroxime (Advanced Reading)
- Cefuroxime Injection, Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
